Literature DB >> 34030047

Glutamate and functional connectivity - support for the excitatory-inhibitory imbalance hypothesis in autism spectrum disorders.

Jennifer E Siegel-Ramsay1, Liana Romaniuk2, Heather C Whalley2, Neil Roberts3, Holly Branigan4, Andrew C Stanfield5, Stephen M Lawrie2, Maria R Dauvermann6.   

Abstract

It has been proposed that the Glutamate (Glu) system is implicated in autism spectrum disorders (ASD) via an imbalance between excitatory and inhibitory brain circuits, which impacts on brain function. Here, we investigated the excitatory-inhibitory imbalance theory by measuring Glu-concentrations and the relationship with resting-state function. Nineteen adult males with ASD and 19 age and sex-matched healthy controls (HC) (23 - 58 years) underwent Proton Magnetic Resonance Spectroscopy of the dorsal anterior cingulate cortex (dACC) and resting-state functional Magnetic Resonance Imaging (fMRI). Glu and Glx concentrations were compared between groups. Seed-based functional connectivity was analyzed with a priori seeds of the right and left dACC. Finally, metabolite concentrations were related to functional connectivity coefficients and compared between both groups. Individuals with ASD showed significantly negative associations between increased Glx concentrations and reduced functional connectivity between the dACC and insular, limbic and parietal regions. In contrast, HC displayed a positive relationship between the same metabolite and connectivity measures. We provided new evidence to support the excitatory-inhibitory imbalance theory, where excitatory Glx concentrations were related to functional dysconnectivity in ASD. Future research is needed to investigate large-scale functional networks in association with both excitatory and inhibitory metabolites in subpopulations of ASD.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anterior cingulate cortex; Glutamate; Glutamate+Glutamine; Magnetic Resonance Imaging; Proton Magnetic Resonance Spectroscopy; Resting-state functional connectivity

Mesh:

Substances:

Year:  2021        PMID: 34030047     DOI: 10.1016/j.pscychresns.2021.111302

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  5 in total

Review 1.  Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors:  Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

Review 2.  Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome.

Authors:  Michele Bertacchi; Chiara Tocco; Christian P Schaaf; Michèle Studer
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

Review 3.  Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research.

Authors:  Roberto Canitano; Roberto Palumbi
Journal:  Front Neurosci       Date:  2021-11-30       Impact factor: 4.677

Review 4.  Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.

Authors:  Martina Montanari; Giuseppina Martella; Paola Bonsi; Maria Meringolo
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

5.  Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder.

Authors:  Neetu Nair; John Patrick Hegarty; Carmen Mihaela Cirstea; Meng Gu; Carrina Brooke Appling; David Quentin Beversdorf
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.